magazine archive
magazine archive
Great Ideas
Why Fevertree continues to fizz with potential
Thursday 20 Feb 2025Fevertree Drinks (FEVR:AIM) 745p Gain to date: 6.6% We urged investors to take a taste of Fevertree Drinks (FEVR:AIM) at 698.5p on 19 December 2024, making the premium mixer drinks firm one of our key 2025 stock selections on the basis the shares were cheap and that negative sentiment towards the...
AB Dynamics is well positioned to drive shareholder value
Thursday 20 Feb 2025AB Dynamics (ABDP:AIM) Price: £18.05 Market Cap: £413 million For those unfamiliar with the story, AB Dynamics (ABDP:AIM) is a leading provider of development, test and verification solutions to the global automotive market. The business was founded in Bradford-on-Avon in 1982 by Tony Best, who...
Hargreaves Services is hard to ignore despite its strong performance
Thursday 13 Feb 2025Hargreaves Services (HSP:AIM) 620p Market cap: £200 million It’s always a test of our conviction if we can recommend a stock just as the shares are touching a 12-month high, but in the case of environmental services, property and materials group Hargreaves Services (HSP:AIM) , its shares are...
BlackRock Frontiers Investment Trust offers a passport to profits
Thursday 13 Feb 2025BlackRock Frontiers Investment Trust (BRFI) 158.5p Market cap: £300 million Investing in frontier markets might seem too risky for some, yet the world’s youngest economies present exciting growth opportunities for adventurous portfolio builders. When high quality, lowly valued companies with their...
This is a great time to invest in the Allianz Technology Trust
Thursday 06 Feb 2025Allianz Technology Trust (ATT) 431p Market cap: £1.63 billion Big technology stocks have dominated growth for more than a decade yet one of the valuable lessons to come out of recent DeepSeek developments is that financial markets are not a one-way street, and key tech stocks don’t always go up...
Futura Medical’s profit warning leaves nagging doubts so exit now
Thursday 06 Feb 2025Futura Medical (FUM:AIM) 16.5p Loss to date: 50% In October 2024, we highlighted sexual health specialist Futura Medical (FUM:AIM) as a great opportunity to get on board as it launched its ED (erectile dysfunction) product Eroxon into the US market through commercial partner Haleon (HLN) . WHAT HAS...
Dial down portfolio risk with dividend growth star Law Debenture
Thursday 06 Feb 2025Law Debenture Corporation (LWDB) 899p Market cap: £1.19 billion Financial markets have been rocked by the twists and turns of the tariff situation created by US president Donald Trump, which threatens to turn into a full-blown trade war. This has spooked investors since it could result in higher...
It’s time to cash in our ‘Get Out Of Jail’ card in Burberry
Thursday 30 Jan 2025Burberry (BRBY) £12.01 Loss to date: 7.2% When we suggested buying shares in UK fashion house Burberry (BRBY) at £12.94 in February 2024, little did we know the bottom was about to fall out of the luxury goods market. WHAT HAS HAPPENED SINCE WE SAID TO BUY? At their nadir in September, after...
Capri is a contrarian pick with identifiable upside catalysts in place
Thursday 30 Jan 2025Capri Holdings (CPRI:NYSE) $24.93 Market cap: $2.94 billion Risk-tolerant investors might want to take a look at Capri (CPRI) , the global fashion luxury group behind iconic brands Versace, Michael Kors and Jimmy Choo. Shares in the New York-listed company have plunged 50% in the past year after...
Trainline should be able to ride out government plans for a state-backed rival
Thursday 30 Jan 2025Trainline (TRN) 366p Gain to date: 11% Since we flagged the stock’s appeal last February, Trainline shares have been steadily rising and the firm has become the number one travel app in Europe. The online ticketing platform has shown investors that it has truly recovered both from the pandemic and...